About

Michael LeFevre, MD, joined the MU Family and Community Medicine faculty in 1984 after graduating from medical school, completing residency and academic fellowship training and earning his Masters of Science in Public Health (MSPH) degree here at the University of Missouri. He teaches residents and medical students in inpatient and outpatient settings and maintains an active practice across the full breadth of family medicine, including inpatient work and — through 2012 — obstetrics.

Education & Training

Medical School

University of Missouri School of Medicine

Residency

Family Medicine

  • University of Missouri Health Care

Post-Graduate School

University of Missouri School of Medicine

Boards

American Board of Family Medicine

Insurances

MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.

In the News

Patients with Chronic Conditions, New Symptoms Should Reschedule Delayed Care (KRCG)

Academic Information

Professor and Chair

Office

One Hospital Drive
M226 Medical Sciences Building, DC032.00
Columbia, MO 65212
United States

P. 573-882-1758

Research Profile

Dr. Michael LeFevre is a national leader in preventive health care.

LeFevre has worn many hats in his 30-year career as a family physician, family medicine educator and public health advocate. He joined the University of Missouri medical school faculty in 1984; from 2002 to 2012, he directed the implementation of MU Health’s electronic health record system, and he currently serves as director of clinical services for the MU Department of Family and Community Medicine. In that role, LeFevre oversees seven medical practices with more than 125,000 patient visits each year. He also maintains an active family medicine practice.

In addition to his work at MU, LeFevre has served as chair of the U.S. Preventive Services Task Force, a panel of volunteer experts striving to improve the health of Americans by making evidence-based recommendations on clinical preventive services. He has published widely on screening for diseases and events such as hepatitis B, aortic aneurysm, oral cancer, suicide risk, vitamin D deficiency and thyroid dysfunction. He also helped develop national guidelines for the treatment of hypertension.

In recognition of his many contributions to the medical field, in 2011 LeFevre was elected to the prestigious Institute of Medicine of the National Academies.

Dr. Michael LeFevre is vice chair and Future of Family Medicine Professor in the Department of Family and Community Medicine at the School of Medicine.

Download the Featured Profile

Awards & Honors

2013

MU School of Medicine/Medical Alumni Organization Citation of Merit

University of Missouri Faculty-Alumni Award

2011

National Academy of Medicine Member (formerly Institute of Medicine)

Publications

2019

Report from the FMAHealth Practice Core Team: achieving the quadruple aim through practice transformation.
Family Medicine. 2019;51(2):193-197.
Marker JE, Davis KN, Etz R, Jones SM, Lee JW, LeFevre M, Phillips R.

The role of home BP monitoring: Answers to 10 common questions: How does home BP monitoring stack up against clinic and ambulatory measurements for the Dx and management of hypertension? Find out in this review.
Journal of Family Practice. 2019;68(1):29-33.
Patil SJ, Koopman RJ, Belden J, LeFevre M.

2018

ACC/AHA Hypertension Guideline: What Is New? What Do We Do?
American Family Physician. 2018;97(6):372-373.
LeFevre M.

Vitamin D screening and supplementation in community-dwelling adults: common questions and answers.
American Family Physician. 2018;97(4):254-260.
LeFevre ML, LeFevre NM.

2017

Atrial fibrillation guideline summary.
Annals of Family Medicine. 2017;15(5):490-491.
Frost JL, Campos-Outcalt D, Hoelting D, LeFevre M, Lin KW, Vaughan W, Bird MD.

From authority to evidence-based medicine: are clinical practice guidelines moving us forward or backward?
Annals of Family Medicine. 2017;15(5):410-412.
LeFevre ML.

It matters what is measured.
Journal of the American Board of Family Medicine: JABFM. 2017;30(1):8-9.
LeFevre ML.

Pharmacologic treatment of hypertension in adults 60 years and older: a guideline you can trust.
American Family Physician. 2017;95(9):547-548.
LeFevre ML, James PA.

Update on the methods of the US Preventive Services Task Force: linking intermediate outcomes and health outcomes in prevention.
American Journal of Preventive Medicine. 2018;54(1S1):S4-S10.
Wolff TA, Krist AH, LeFevre M, Jonas DE, Harris RP, Siu A, Owens DK, Gillman MW, Ebell MH, Herzstein J, Chou R, Whitlock E, Bibbins-Domingo K.

2016

Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement.
Annals of Internal Medicine. 2016;164(12):836-845.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., Garc+¡a FAR, Gillman M, Harper DM, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phillips WR, Phipps MG, Pignone MP, Siu AL, Owens DK, LeFevre ML.

Convergence and divergence around breast cancer screening.
Annals of Internal Medicine. 2016;164(4):301-302.
Siu AL, Bibbins-Domingo K, Grossman DC, LeFevre ML, U.S.Preventive Services Task Force.

In individuals at intermediate risk for cardiovascular disease, treatment with rosuvastatin but not candesartan plus hydrochlorothiazide lowers cardiovascular disease even rates.
Evidence Based Medicine. 2016;DOI: 10.1136/ebmed-2016-110523
LeFevre ML.

Is it time for the USPSTF to inform-but not determine-coverage?
Annals of Internal Medicine. 2016;165(12):876-877.
Moyer VA, LeFevre M, Calonge N.

Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement.
JAMA. 2016;316(6):625-633.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., Garcia FAR, Gillman MW, Kemper AR, Krist AH, Kurth AE, Seth Landefeld C, LeFevre M, Mangione CM, Phillips WR, Phipps MG, Pignone MP, Siu AL.

Sexually transmitted infections: recommendations from the U.S. Preventive Services Task Force.
American Family Physician. 2016;94(11):907-915.
Lee KC, Ngo-Metzger Q, Wolff T, Chowdhury J, LeFevre ML, Meyers DS.

Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.
JAMA. 2016;316(19):1997-2007.
US Preventive Services, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., Garcia FA, Gillman MW, Kemper AR, Krist AH, Kurth AE, Landefeld CS, LeFevre ML, Mangione CM, Phillips WR, Owens DK, Phipps MG, Pignone MP.

Use of decision models in the development of evidence-based clinical preventive services recommendations: methods of the U.S. Preventive Services Task Force.
Annals of Internal Medicine. 2016;165(7):501-508.
Owens DK, Whitlock EP, Henderson J, Pignone MP, Krist AH, Bibbins-Domingo K, Curry SJ, Davidson KW, Ebell M, Gillman MW, Grossman DC, Kemper AR, Kurth AE, Maciosek M, Siu AL, LeFevre ML, U.S.Preventive Services Task Force.

2015

Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement.
Annals of Internal Medicine. 2015;162(9):641-650.
LeFevre ML, U.S. Preventive Services Task Force.

Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement.
Annals of Internal Medicine. 2015;162(2):133-140.
LeFevre ML, U.S. Preventive Services Task Force.

Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Summaries for Patients.
Annals of Internal Medicine. 2015;162(2):I-28
LeFevre ML, U.S. Preventive Services Task Force.

Update on the methods of the US Preventive Services Task Force: methods for understanding certainty and net benefit when making recommendations.
American Journal of Preventive Medicine. 2018;54(1S1):S11-S18.
Krist AH, Wolff TA, Jonas DE, Harris RP, LeFevre ML, Kemper AR, Mangione CM, Tseng CW, Grossman DC.